中 | EN
  • Home
  • About Us
    1. Introduction
    2. Subsidiaries
    3. Vision & Culture
    4. History
  • Products
  • R&D
    1. R&D Team
    2. Technical Platform
    3. Upcoming Products
  • Investors
    1. Corporate Data
    2. Announcements
    3. Financial Reports
    4. Offering Documents
    5. Corporate Governance
    6. Investor Query
  • News
    1. Dynamics
    2. Media Reports
    3. Media Inquiry
  • Career
    1. Talents
    2. Jobs
  • Contact

PRODUCTS

Home>Products
  • Recombinant
    Hepatitis B Vaccine

    AIM Hanxin

  • Freeze-dried Human
    Rabies Vaccine
    (Vero cell)

    Rong'an Bio

  • Inactivated Hepatitis
    A Vaccine
    (Human diploid cell)

    AIM Kanghuai

  • Live Attenuated
    Parotitis Vaccine

    AIM Weixin

  • Inactivated HFRS
    Vaccine

    AIM Weixin

  • ACYW135
    Meningococcus
    Polysaccharide Vaccine
    (MPSV4)

    AIM Weixin

  • About Us

    1. Introduction
    2. Vision & Culture
    3. History
    4. Subsidiaries
  • Products

    1. Recombinant Hepatitis B Vaccine
    2. Freeze-dried Human Rabies Vaccine
    3. Inactivated Hepatitis A Vaccine
    4. Live Attenuated Parotitis Vaccine
    5. Inactivated HFRS Vaccine
    6. ACYW135 Meningococcus Polysaccharide Vaccine
  • R&D

    1. R&D Team
    2. Technical Platform
    3. Upcoming Products
  • Investors

    1. Corporate Data
    2. Announcements
    3. Financial Reports
    4. Offering Documents
    5. Corporate Governance
    6. Investor Query
  • Career

    1. Talents
    2. Jobs
    3. Corporate WeChat

  • Links

    1. National Health Commission of the People’s Republic of China
    2. National Medical Products Administration
    3. Chinese Center for Disease Control and Prevention
    4. National Institutes for Food and Drug Control
    5. Chinese Journal of Vaccines and Immunization
© 2022 艾美疫苗股份有限公司 All rights reserved. 京ICP备20027818号-1 京公网安备11010502045274号